Shri Ahimsa Naturals Ltd
Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts.[1]
- Market Cap ₹ 714 Cr.
- Current Price ₹ 305
- High / Low ₹ 310 / 147
- Stock P/E 26.4
- Book Value ₹ 72.5
- Dividend Yield 0.00 %
- ROCE 24.4 %
- ROE 18.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 79.1% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 32.2%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 62.9 to 96.2 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Food Products Other Food Products
Part of Nifty SME Emerge
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 22 | 28 | 58 | 104 | 78 | 96 | 116 | |
| 18 | 24 | 41 | 54 | 51 | 65 | 81 | |
| Operating Profit | 4 | 4 | 17 | 50 | 27 | 31 | 35 |
| OPM % | 17% | 15% | 30% | 48% | 34% | 32% | 30% |
| 1 | 0 | 1 | 2 | 1 | 2 | 4 | |
| Interest | 2 | 1 | 2 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | 2 | 2 | 16 | 51 | 25 | 30 | 37 |
| Tax % | 27% | 32% | 30% | 29% | 26% | 26% | |
| 1 | 2 | 11 | 36 | 19 | 22 | 27 | |
| EPS in Rs | 3.44 | 3.37 | 21.53 | 68.21 | 10.21 | 9.42 | 11.61 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 35% |
| 3 Years: | 18% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 79% |
| 3 Years: | 25% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 105% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 33% |
| 3 Years: | 32% |
| Last Year: | 19% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 5 | 5 | 5 | 18 | 23 | 23 |
| Reserves | 6 | 9 | 22 | 58 | 66 | 131 | 146 |
| 14 | 13 | 6 | 3 | 14 | 0 | 0 | |
| 4 | 4 | 7 | 8 | 5 | 38 | 10 | |
| Total Liabilities | 27 | 31 | 41 | 74 | 103 | 193 | 180 |
| 15 | 17 | 21 | 28 | 32 | 39 | 39 | |
| CWIP | 0 | 1 | 3 | 3 | 6 | 2 | 0 |
| Investments | 0 | 0 | 0 | 1 | 10 | 10 | 20 |
| 12 | 12 | 17 | 42 | 55 | 143 | 121 | |
| Total Assets | 27 | 31 | 41 | 74 | 103 | 193 | 180 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 6 | 3 | 14 | 20 | 6 | 43 | |
| -1 | -4 | -6 | -10 | -19 | -3 | |
| -5 | 1 | -6 | -4 | 10 | 34 | |
| Net Cash Flow | 0 | -0 | 3 | 7 | -4 | 74 |
| Free Cash Flow | 5 | -1 | 9 | 10 | -2 | 39 |
| CFO/OP | 162% | 84% | 91% | 68% | 46% | 161% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 53 | 62 | 25 | 39 | 53 | 96 |
| Inventory Days | 201 | 61 | 77 | 122 | 340 | 214 |
| Days Payable | 45 | 33 | 15 | 8 | 18 | 3 |
| Cash Conversion Cycle | 209 | 90 | 87 | 154 | 375 | 307 |
| Working Capital Days | -30 | -3 | 26 | 74 | 133 | 92 |
| ROCE % | 14% | 58% | 102% | 32% | 24% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Export Share of Total Revenue % |
|
|||
| Gross Current Assets (GCA) Days Days |
||||
| Installed Capacity - Caffeine Anhydrous Natural MTPA |
||||
| Installed Capacity - Green Coffee Bean Extract MTPA |
||||
| Inventory Holding Period Days |
||||
| Number of Countries with Sales Presence Count |
||||
| Number of Permanent Employees Count |
||||
Extracted by Screener AI
Documents
Announcements
-
Allotment of Securities
13 May 2026 - Revised board outcome corrects details for allotment of 3,77,600 equity shares on warrant conversion.
-
Outcome of Board Meeting
13 May 2026 - Revised board outcome corrects warrant-conversion allotment of 3,77,600 shares at ₹227 each.
-
Allotment of Securities
12 May 2026 - Board allotted 3,77,600 equity shares at ₹227 on warrant conversion, increasing paid-up capital to ₹23.81 crore.
-
Disclosure under SEBI Takeover Regulations
12 May 2026 - Prerna Jain has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance …
-
Outcome of Board Meeting
12 May 2026 - Board allotted 3,77,600 shares at ₹227 on warrant conversion, raising paid-up capital to ₹23.81 crore.
Business Profile[1]
The Company is engaged in extracting and manufacturing Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE), and Crude Caffeine, and trading in herbal extracts. It supplies food & beverages, nutraceuticals, cosmetics, and pharmaceutical industries.